CClinicalTrials.gg
Status unknownNCT04539782Updated Sep 7, 2020

A Feasibility Study on the Value of Pelvic Floor Training After Pelvic Organ Prolapse Surgery

An interventional study of Physiotherapy intervention in Pelvic Organ Prolapse, sponsored by Landspitali University Hospital. Status unknown at 1 site in Iceland. Open to female participants aged Up to 80 Years. Per ClinicalTrials.gov, last updated 2020-09-07.

Sponsored by Landspitali University Hospital · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2020), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
Up to 80 Years
Sex
Female
01

Study summary

The main objective is to assess the feasibility of a randomized controlled trial that investigates the effects of pelvic floor training on recurrence in pelvic organ prolapse surgeries. This will be achieved by measuring POP-Q stage and by a validated questionnaire before surgery and one year after. Women having POP surgery at Landspitali will be offered to participate if they meet the criteria of the research. Participants will be randomized into two groups, interventions and control group that gets standard care at the hospital. The intervention group will meet a physiotherapist 6 weeks post-op for targeted physiotherapy with pelvic floor training, conventional advice and support. Over 16 weeks period participants in intervention group will get physiotherapy four times and get two follow up phone calls. Pelvic floor activity will be measured with EMG and symptoms collected with questionnaire before surgery and year post-op.

Recurrent surgeries are common problem shortly after the first one. POP symtoms can be bothersome for women and reduce their quality of life. More knowledge is needed to figure out if targeted physiotherapy with pelvic floor training can help reduce recurrency and bothersome symptoms.

Read the detailed description

A feasibility study to assess the practicality of physiotherapy treatment after pelvic organ prolapse (POP) surgery and the effect on recurrent POP symptoms, pelvic floor activity and general physical fitness.

Pelvic organ prolapse is a common problem among women and many do need surgery. Little is known about recurrence of POP surgeries. Pelvic floor muscle training (PFMT) has positive effects on POP symptoms and quality of life. Research shows PFMT can reduce stage of the prolapse.

Before surgery POP-Q stage will be measured by urogynocologist. Pelvic floor muscle activity will be measured with EMG vaginal probes. General physical fitness will be tested with 30s chair-stand and core strenght with prone bride test. An Icelandic version of The Australian Female PelvicFloor questionnaire will be used to assess symptoms and affect on quality of life.

Participants will be randomized into two groups, intervention and control group. The control group gets standard care at the hospital. The interventional group gets physiotherapy with PFMT, conventional advise and support. During 16 weeks intervention participants get four sessions with specialized physiotherapist and two follow up phone calls. Follow up measures will be made at 12 months.

02

Conditions studied

  • Pelvic Organ Prolapse

Keywords

  • pelvic floor
  • physiotherapy
  • pelvic organ prolapse
  • post op
  • recurrence
03

In context

Prolapse

676 studies on the registry are indexed under Prolapse; 79 are open to participants now.

This study's planned enrollment of 50 is below the median of 74 across 435 interventional studies indexed under Prolapse.

Browse Prolapse studies →

Lead sponsor

Landspitali University Hospital is the lead sponsor of 20 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women having their first POP surgery at LSH
  • \<80 years old
  • Icelandic speaking

Exclusion criteria

Exclusion Criteria:

  • Women that previously have had incontinence surgery, hysterectomy or previous POP surgery.
  • Dementia, physical disabilities that could affect the research, previous radiotherapy and neurological diseases.
  • Women participating in the research that need to have recurrent POP surgery or incontinence surgery within the year of the surgery.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Physiotherapy intervention

    Pelvic floor muscle training given by a physiotherapist in four sessions and follow up phone calls twice in 14 weeks

    Other: Physiotherapy intervention

  • No intervention
    No intervention

    Standard care

Interventions

  • OtherPhysiotherapy intervention

    Compare the effect of structured pelvic floor muscle training supported by physiotherapist post operation on POP on recurrence of symptoms or symptoms in a new compartment, quality of life and pelvic floor muscle function.

06

What researchers measure

Primary outcomes

  1. POP-Q

    POP-Q stages are measured by urogynocologists who are blinded outcome assessors.

    Time frame: One year

Secondary outcomes

  1. The Australian Female Pelvic Floor Questionnaire

    Pelvic floor symptoms

    Time frame: One year

07

Study locations

1 site
  • Landspitali University Hospital
    Reykjavík, 101, Iceland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 7, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04539782
Lead sponsor
Landspitali University Hospital
Collaborators
University of Iceland
Responsible party
Sponsor
First posted
Sep 7, 2020
Start date
Jun 10, 2020
Primary completion
Jun 15, 2021 (estimated)
Completion
Jun 15, 2021 (estimated)
Last update
Sep 7, 2020

Study contacts

Þorgerður Sigurðardóttir, MSc
principal investigator · Landspítali University Hospital/University of Iceland, Reykjavík, Iceland.
Helga Medek, MD, MSc
study chair · Landspítali University Hospital/University of Iceland, Reykjavík, Iceland.
Þórarinn Sveinsson, PhD
study chair · University of Iceland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion